MicroPort Scientific Corp (MCRPF)
0.70
-0.10
(-12.50%)
USD |
OTCM |
Apr 17, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.284B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -72.87% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.343 |
| Price to Book Value | 1.694 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 2.067 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 91.54% |
Profile
| MicroPort Scientific Corp develops, makes, and markets medical devices in four major segments: orthopedics, cardiovascular, cardiac rhythm management, and others. The orthopedics business sells reconstructive joints, spine, trauma, and sports medicine products, and other implants and equipment. The cardiovascular devices business sells products for the treatment of coronary artery disease. The CRM business develops and manufactures defibrillators, cardiac therapy devices, and pacemakers. The other business sells endovascular, electrophysiological, neurovascular, and surgical devices. MicroPort Scientific generates the largest proportion of its revenue in China. |
| URL | https://www.microport.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Aug. 30, 2024 (est.) |
| Last Earnings Release | Mar. 28, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 28, 2021 |
Ratings
Profile
| MicroPort Scientific Corp develops, makes, and markets medical devices in four major segments: orthopedics, cardiovascular, cardiac rhythm management, and others. The orthopedics business sells reconstructive joints, spine, trauma, and sports medicine products, and other implants and equipment. The cardiovascular devices business sells products for the treatment of coronary artery disease. The CRM business develops and manufactures defibrillators, cardiac therapy devices, and pacemakers. The other business sells endovascular, electrophysiological, neurovascular, and surgical devices. MicroPort Scientific generates the largest proportion of its revenue in China. |
| URL | https://www.microport.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Aug. 30, 2024 (est.) |
| Last Earnings Release | Mar. 28, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 28, 2021 |